Real Research, Real Results

AutismFreeBrain, Inc. is a nonprofit organization that
promotes a breakthrough in Autism Spectrum Disorder (ASD)
research. Researchers at some of the most prestigious medical
universities in the US have found a medical cause of autism
and are translating these scientific findings into day-to-day
applications. Our commitment is to continue funding this
research to provide a medical test for early diagnosis,
presentation, and therapies for timely intervention.

Why is there no ASD cure yet?

Annual US Research Funding for Major Diseases (in Million $)

Autism funding is needed!
Although each year more children are
diagnosed with ASD than people with
cancer, AIDS and diabetes combined,
only 2% of total US medical research funding
is spent on ASD.

Four years of published research - funded by the
National Autism Association (NAA), the Autism
Research Institute (ARI), and other organizations -
has discovered that a largely unexplored autoimmune
condition was a major, if not primary, cause of autism.
It has been found that this autoimmune condition is
responsible for disrupting brain communications in
people with ASD and our goal is to diagnose and
block this autoimmune reaction.

Can We Truly Put an End to Autism?

Four years of published research point to a cure.

Our Top 5 Findings

Brain Immunity Storms damage behavior and language brain regions affected in ASD
Autoimmune condition found to damage behavior and language brain regions and lead to ASD
A novel molecule, found to cause inflammation, will be targeted to inhibit Brain Immunity Storms
A cell in the immune system found to be central to ASD can be targeted to inhibit Autism
Two blood biomarkers can be used for early and objective ASD diagnosis
A blood test can be used for early and objective ASD diagnosis
Laboratory experiments showed that Brain Immunity Storms can be prevented and reversed
Laboratory experiments showed that Autism can be prevented and reversed
Clinical trials show that a unique natural formulation benefits 75% of children with ASD
A new treatment that benefits most children and allows them to developmentally "catch up" to their neurotypical peers